Contact this trialFirst, we need to learn more about you.
Iberdomide Maintenance Therapy for Multiple Myeloma
Recruiting1 awardPhase 2
New York, New York
This trial will test if iberdomide is a safe and effective maintenance therapy for people with Multiple Myeloma who have had an Autologous Hematopoietic Stem Cell Transplant and have already had lenalidomide as maintenance therapy.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service